Management of hepatitis B: 2000 - Summary of a workshop

被引：611

作者：

Lok, AS

Heathcote, EJ

Hoofnagle, JH

机构：

[1] Univ Michigan, Dept Clin Hepatol, Div Gastroenterol, Ann Arbor, MI 48109 USA

[2] Univ Toronto, Toronto Western Hosp, Div Gastroenterol, Toronto, ON M5T 2S8, Canada

[3] NIDDKD, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA

来源：

关键词：

D O I：

10.1053/gast.2001.24839

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1828 / 1853

页数：26

共 210 条

[1] Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B
Angus, PW
McCaughan, GW
Gane, EJ
Crawford, DHG
Harley, H
[J]. LIVER TRANSPLANTATION, 2000, 6 (04) : 429 - 433
[2] Atkins M, 1998, HEPATOLOGY, V28, p319A
[3] Bartholomeusz A, 2000, HEPATOLOGY, V32, p457A
[4] BATHOLOMEW MM, 1997, LANCET, V349, P20
[5] BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
[6] 2-J
[7] An algorithm for the grading of activity in chronic hepatitis C
Bedossa, P
Poynard, T
[J]. HEPATOLOGY, 1996, 24 (02) : 289 - 293
[8] Benhamou Y, 2000, HEPATOLOGY, V32, p459A
[9] Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
Benhamou, Y
Bochet, M
Thibault, V
Di Martino, V
Caumes, E
Bricaire, F
Opolon, P
Katlama, C
Poynard, T
[J]. HEPATOLOGY, 1999, 30 (05) : 1302 - 1306
[10] INHIBITION OF HEPATITIS-B VIRUS BY ANTISENSE OLIGODEOXYNUCLEOTIDES
BLUM, HE
GALUN, E
VONWEIZSACKER, F
WANDS, JR
[J]. LANCET, 1991, 337 (8751) : 1230 - 1230